Crescent Biopharma, Inc. (NASDAQ:CBIO – Get Free Report) CEO Joshua Brumm sold 42,305 shares of the stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $17.99, for a total value of $761,066.95. Following the completion of the transaction, the chief executive officer directly owned 281,212 […]